Concord Biotech Ltd. Conference Calls and Earnings Call Transcripts

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated January 31, 2025 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for third quarter and Nine Months ended December 31, 2024, we wish to inform that the said Earning Call was held today at 04:00 PM (IST).

pdf

Concord Biotech Ltd.

19 Nov 2024

1543.60

1.35%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The transcripts of the earning calls for the second quarter ended 30 September 2024 is enclosed herewith. Kindly take the same into your records.

pdf

Concord Biotech Ltd.

12 Nov 2024

1543.60

1.35%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated November 06, 2024 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for Second Quarter and half year ended September 30, 2024, we wish to inform that the said Earning Call was held today at 02:00 PM (IST).

pdf

Concord Biotech Ltd.

12 Nov 2024

1543.60

1.35%

Concord Biotech Results Earnings Call for Q2FY25

Conference Call with Concord Biotech Management and Analysts on Q2FY25 Performance and Outlook. Listen to the full earnings transcript.

Concord Biotech Ltd.

20 Aug 2024

1543.60

1.35%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

The transcripts of the earning calls for the first quarter ended June 30, 2024 is enclosed herewith. kindly take the same into your records.

pdf

Concord Biotech Ltd.

12 Aug 2024

1543.60

1.35%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated August 07, 2024 to the Stock exchanges regarding Earning call in respect of the unaudited (Standalone and Consolidated) Financial Results of the company for the First Quarter ended on June 30, 2024, we wish to inform that the said Earning Call was held today at 03:30 PM (IST). Kindly take the above on records.

pdf

Concord Biotech Ltd.

04 Jun 2024

1543.60

1.35%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcripts of Q4 & FY24 Earning call Held on May 28, 2024

pdf

Concord Biotech Ltd.

28 May 2024

1543.60

1.35%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Pursuant to the provision of Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, and further to our intimation dated May 21, 2024 to the Stock exchanges regarding Earning call in respect of the audited (Standalone and Consolidated) Financial Results of the company for the fourth Quarter and year ended March 31, 2024, we wish to inform that the said Earning Call was held today at 04:00 PM (IST). The audio recording of the conference call has been hosted on the website of the company and link to access the said recording is as follows: - Link :- https://www.concordbiotech.com/public/assets/pdf/Q4FY24-earning-call-audio.mp3 Kindly take the above on records.

pdf

Concord Biotech Ltd.

16 Feb 2024

1543.60

1.35%

Earnings Call

Concord Biotech Ltd - 543960 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

In Continuation of our letter dated February 09, 2024 regarding audio recording of the unaudited (Standalone and Consolidated) financial results of the company for the Third Quarter and Nine months ended December 31, 2023 , transcripts of the earnings call for the said period enclosed herewith and available on the website of the company at the following link after sending this letter to you, https://www.concordbiotech.com/investors

pdf

Concord Biotech Ltd. Conference Calls and Earnings Call Transcripts